A Foundation
The API unit based in Dholka, Ahmedabad (Unit-1), is spread across 112,302 square meters and has 22 manufacturing blocks with a total fermentation capacity of 450m3. The fermentation manufacturing blocks are well supported by chemical synthesis, downstream recovery blocks and powder processing areas.
The manufacturing facility complies with cGMP and has been inspected by global regulatory agencies like U.S. Food & Drug Administration (USFDA), European Union Goods Manufacturing Practice (EUGMP), Japanese Accreditation of Foreign Manufacturers (AFM), Korean Food & Drug Administration & State Goods Manufacturing Practice of India (GMP) EU Regulatory authority (Bavaria, Germany), ANVISA (Brazil), Russian FDA.
Concord has commercialised APIs across niche therapeutic segments like Immunosuppressant, Oncology, Anti-fungal, and Anti-bacterial.
The manufacturing facility complies with cGMP and has been inspected by global regulatory agencies like U.S. Food & Drug Administration (USFDA), European Union Goods Manufacturing Practice (EUGMP), Japanese Accreditation of Foreign Manufacturers (AFM), Korean Food & Drug Administration & State Goods Manufacturing Practice of India (GMP) EU Regulatory authority (Bavaria, Germany), ANVISA (Brazil), Russian FDA.
Concord has commercialised APIs across niche therapeutic segments like Immunosuppressant, Oncology, Anti-fungal, and Anti-bacterial.
